Augusto Consoli

専門分野: Psychiatrist
41年の経験
話します:
English, Italian
オンラインコンサルテーション：利用可能
勤務先: イタリア, ボローニャ, Lucia Magnani Health Clinic
Significantly contributed to a prospective study on the safety and effectiveness of levomethadone for opioid addiction treatment in Italy.
Dr. Augusto Consoli is a specialist in psychotherapy. He focuses on treating opioid addiction. He played a key role in the LEVOPROACT study, which evaluated the safety and effectiveness of levomethadone for opioid maintenance therapy.

Dr. Consoli helped design the study, collect data, and prepare the manuscript. He worked with several centers across Italy. The interim results showed that levomethadone has a good safety profile, especially for QT interval safety. It also helps reduce opioid craving. These findings are an important step forward in addiction therapy.

Augusto Consoliとのオンラインコンサルテーション

便利で簡単

100%安全で機密

お問い合わせください

医師のサービス

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Dr. Augusto Consoli has demonstrated his dedication and expertise in the field of Psychotherapy, with a particular focus on opioid addiction treatment. His significant contribution to a prospective study on the safety and effectiveness of levomethadone showcases his commitment to advancing medical knowledge and patient care.

Research Contributions

Played a crucial role in an observational, prospective study focusing on the safety and effectiveness of levomethadone in subjects undergoing opioid maintenance treatment (LEVOPROACT study).
Contributed to the study design, data collection, and interpretation.
Participated in manuscript writing, editing, and approval for submission.
Collaborated with principal investigators from various participant centers across Italy.

Study Findings

The study evaluated the safety profile of levomethadone, particularly its effects on the QT interval on an electrocardiogram, and its effectiveness in reducing craving and opioid use.
The interim analysis of the study yielded encouraging preliminary results, showing effectiveness of treatment with a favorable risk/benefit ratio for levomethadone therapy.